Vardenafil Completed Phase 2 / 3 Trials for Erectile Dysfunction (ED) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT00786253Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction
NCT01168817Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors